190 related articles for article (PubMed ID: 29605152)
1. Pharmacologic Hemostatic Agents in Total Joint Arthroplasty-A Cost-Effectiveness Analysis.
Ramkumar DB; Ramkumar N; Tapp SJ; Moschetti WE
J Arthroplasty; 2018 Jul; 33(7):2092-2099.e9. PubMed ID: 29605152
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
[TBL] [Abstract][Full Text] [Related]
3. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
4. Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty.
Churchill JL; Puca KE; Meyer E; Carleton M; Anderson MJ
J Knee Surg; 2017 Jun; 30(5):460-466. PubMed ID: 27699724
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
[TBL] [Abstract][Full Text] [Related]
6. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty.
Tuttle JR; Ritterman SA; Cassidy DB; Anazonwu WA; Froehlich JA; Rubin LE
J Arthroplasty; 2014 Aug; 29(8):1512-5. PubMed ID: 24630599
[TBL] [Abstract][Full Text] [Related]
7. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
[TBL] [Abstract][Full Text] [Related]
8. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid versus aminocaproic acid for blood management after total knee and total hip arthroplasty: A systematic review and meta-analysis.
Liu Q; Geng P; Shi L; Wang Q; Wang P
Int J Surg; 2018 Jun; 54(Pt A):105-112. PubMed ID: 29723672
[TBL] [Abstract][Full Text] [Related]
10. Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: A randomized clinical trial.
Wu Y; Zeng Y; Hu Q; Li M; Bao X; Zhong J; Shen B
Thromb Res; 2018 Nov; 171():143-148. PubMed ID: 30312799
[TBL] [Abstract][Full Text] [Related]
11. Effect of Tranexamic Acid on Transfusion Rates Following Total Joint Arthroplasty: A Cost and Comparative Effectiveness Analysis.
Evangelista PJ; Aversano MW; Koli E; Hutzler L; Inneh I; Bosco J; Iorio R
Orthop Clin North Am; 2017 Apr; 48(2):109-115. PubMed ID: 28336035
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of use of tranexamic Acid to prevent major bleeding complications in hip and knee arthroplasty surgery.
Slover J; Bosco J
Am J Orthop (Belle Mead NJ); 2014 Oct; 43(10):E217-20. PubMed ID: 25303447
[TBL] [Abstract][Full Text] [Related]
13. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
[TBL] [Abstract][Full Text] [Related]
14. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty.
Gillette BP; Maradit Kremers H; Duncan CM; Smith HM; Trousdale RT; Pagnano MW; Sierra RJ
J Arthroplasty; 2013 Sep; 28(8 Suppl):137-9. PubMed ID: 23886409
[TBL] [Abstract][Full Text] [Related]
15. Blood Conservation Using Tranexamic Acid Is Not Superior to Epsilon-Aminocaproic Acid After Total Knee Arthroplasty.
Boese CK; Centeno L; Walters RW
J Bone Joint Surg Am; 2017 Oct; 99(19):1621-1628. PubMed ID: 28976426
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid: optimal blood loss management in surface replacement arthroplasty.
Sassoon A; Nam D; Jackups R; Johnson SR; Nunley RM; Barrack RL
Bone Joint J; 2016 Feb; 98-B(2):173-8. PubMed ID: 26850421
[TBL] [Abstract][Full Text] [Related]
17. Tranexamic Acid in Hip and Knee Arthroplasty.
Melvin JS; Stryker LS; Sierra RJ
J Am Acad Orthop Surg; 2015 Dec; 23(12):732-40. PubMed ID: 26493971
[TBL] [Abstract][Full Text] [Related]
18. Comparing Cost, Efficacy, and Safety of Intravenous and Topical Tranexamic Acid in Total Hip and Knee Arthroplasty.
DiBlasi JF; Smith RP; Garavaglia J; Quedado J; Frye BM; Dietz MJ
Am J Orthop (Belle Mead NJ); 2016; 45(7):E439-E443. PubMed ID: 28005108
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic versus aminocaproic acids in patients with total hip arthroplasty: a retrospective study.
Xie H; Yang YS; Tian SM; Wang BJ; Fu WM; Cheng LL; Jiang NN; Gu G; Zhao DW
BMC Musculoskelet Disord; 2022 Nov; 23(1):999. PubMed ID: 36401231
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness and safety of aminocaproic acid for reducing blood loss in total knee and hip arthroplasty: A meta-analysis.
Dong Q; Zhang Y; Sun X; Hu F
Int J Surg; 2018 Apr; 52():156-163. PubMed ID: 29471157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
